Literature DB >> 16263245

The genetics of type 1 diabetes: lessons learned and future challenges.

Suna Onengut-Gumuscu1, Patrick Concannon.   

Abstract

It has been more than 30 years since the first evidence was published suggesting the involvement of a specific chromosomal region, HLA, in modulating the risk for type 1 diabetes (T1D). In the intervening years, what have we learned regarding the identities of specific loci that modulate T1D risk, and what lessons have these studies provided that might be helpful in finding and characterizing additional susceptibility loci both for T1D and other autoimmune disorders? In the following review, we briefly address these issues.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16263245     DOI: 10.1016/j.jaut.2005.09.007

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  9 in total

Review 1.  Genetic epidemiology of type 1 diabetes.

Authors:  Andrew D Paterson
Journal:  Curr Diab Rep       Date:  2006-04       Impact factor: 4.810

Review 2.  A propos time and autoimmunity.

Authors:  Pablo I Martín; Ana I Malizia; E Rewald
Journal:  Clin Rev Allergy Immunol       Date:  2008-06       Impact factor: 8.667

3.  Genetic mapping at 3-kilobase resolution reveals inositol 1,4,5-triphosphate receptor 3 as a risk factor for type 1 diabetes in Sweden.

Authors:  Jared C Roach; Kerry Deutsch; Sarah Li; Andrew F Siegel; Lynn M Bekris; Derek C Einhaus; Colleen M Sheridan; Gustavo Glusman; Leroy Hood; Ake Lernmark; Marta Janer
Journal:  Am J Hum Genet       Date:  2006-08-30       Impact factor: 11.025

4.  Tg.2098 is a major human thyroglobulin T-cell epitope.

Authors:  Francesca Menconi; Amanda Huber; Roman Osman; Erlinda Concepcion; Eric M Jacobson; Mihaela Stefan; Chela S David; Yaron Tomer
Journal:  J Autoimmun       Date:  2010-03-19       Impact factor: 7.094

Review 5.  Influence of host immunoregulatory genes, ER stress and gut microbiota on the shared pathogenesis of inflammatory bowel disease and Type 1 diabetes.

Authors:  Altin Gjymishka; Roxana M Coman; Todd M Brusko; Sarah C Glover
Journal:  Immunotherapy       Date:  2013-12       Impact factor: 4.196

6.  Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetes.

Authors:  Angela Lombardi; Erlinda Concepcion; Hanxi Hou; Hanane Arib; Mihaly Mezei; Roman Osman; Yaron Tomer
Journal:  J Autoimmun       Date:  2020-09-17       Impact factor: 7.094

7.  Associations between TNF gene polymorphisms (-308 A/G, -238 A/G, -1031 C/T and -857 T/C) and genetic susceptibility to T1D: a meta-analysis.

Authors:  Peng-Fei Wen; Xiao-Song Wang; Min Zhang; Han Cen; Hai-Feng Pan; Qian-Ling Ye; Chen Mao; Dong-Qing Ye
Journal:  Endocrine       Date:  2014-02-11       Impact factor: 3.633

Review 8.  Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms.

Authors:  Amanda Huber; Francesca Menconi; Sarah Corathers; Eric M Jacobson; Yaron Tomer
Journal:  Endocr Rev       Date:  2008-09-05       Impact factor: 19.871

9.  Genetic variation within the HLA class III influences T1D susceptibility conferred by high-risk HLA haplotypes.

Authors:  A M Valdes; G Thomson; L F Barcellos
Journal:  Genes Immun       Date:  2010-01-07       Impact factor: 2.676

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.